New Migraine treatment now fully funded for NZ migraine sufferers
The estimated 400,000 New Zealanders who suffer from migraine now have another choice of fully funded medication to battle this debilitating disorder.
MAXALT MLT® is unique* in that it is formulated as a "wafer" that dissolves on the tongue and does not require water. This is good news for the many sufferers who struggle to take tablets due to nausea brought on by migraines.
MAXALT MLT 10mg is a treatment for acute migraine attacks and belongs to the class of medicines known as “triptans” (5HT1B/1D agonists). Clinical studies have shown MAXALT MLT works quickly (as early as 30 minutes) and MAXALT MLT relieved pain for more patients after two hours than other orally administered triptans."
MAXALT has received regulatory approval in 69 countries around the world since the product first launched in 1998.
